Elanco Animal Health (NYSE:ELAN) will replace Sarepta Therapeutics (NASDAQ:SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace Brookline Bancorp (NASDAQ:BRKL) in the S&P SmallCap 600, effective before the opening of trading on Tuesday, September 2.
S&P SmallCap 600
